Nicholas Augustinos - May 21, 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Nicholas Augustinos
Stock symbol
DXCM
Transactions as of
May 21, 2021
Transactions value $
$1
Form type
4
Date filed
5/25/2021, 07:15 PM
Next filing
Jun 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Other $0 +2.19K +271.96% $0.00 3K Mar 18, 2021 Direct F1, F2
transaction DXCM Common Stock Award $0.92 +918 +30.62% $0.00* 3.92K May 21, 2021 Direct F3, F4
transaction DXCM Common Stock Other $0 -2.19K -21.72% $0.00 7.9K Mar 18, 2021 by Trust F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred from ownership under the Kirschner/Augustinos Revocable Trust to direct ownership.
F2 Included in this number are 806 restricted stock units which were granted on May 22, 2020 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting.
F3 The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F4 Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.
F5 Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.